Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis
Open Access
- 1 January 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 61 (1), 23-32
- https://doi.org/10.1093/jnen/61.1.23
Abstract
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Most patients undergo an initial relapsing-remitting (RR-MS) course that transforms into a relentless neurodegenerative disorder, termed secondary progressive (SP)-MS. Reversible inflammation and demyelination account readily for the pattern of RR-MS but provide an unsatisfactory explanation for irrevocable decline in SP-MS. Axon loss is thought to be responsible for progressive, non-remitting neurological disability during SP-MS. There is considerable potential for neuroprotective therapies in MS, but their application awaits animal models in which axonal loss correlates with permanent neurological disability. In this report, we describe quantitative immunohistochemical methods that correlate inflammation and axonal loss with neurological disability in chronic-relapsing experimental autoimmune encephalomyelitis (EAE). At first attack, CNS inflammation, but not axon loss, correlated with the degree of neurological disability. In contrast, fixed neurological impairment in chronic EAE correlated with axon loss that, in turn, correlated with the number of symptomatic attacks. As proposed for MS, these observations imply a causal relationship between inflammation, axon loss, and irreversible neurological disability. This chronic-relapsing EAE model provides an excellent platform for 2 critical objectives: investigating mechanisms of axon loss and evaluating efficacy of neuroprotective therapies.Keywords
This publication has 49 references indexed in Scilit:
- Identification of Genetic Loci Controlling the Characteristics and Severity of Brain and Spinal Cord Lesions in Experimental Allergic EncephalomyelitisThe American Journal of Pathology, 2000
- Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosisAnnals of Neurology, 2000
- Demyelinating Diseases -- New Pathological Insights, New Therapeutic TargetsNew England Journal of Medicine, 1998
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- The role of CD45 and CD45‐associated molecules in T cell activationImmunology & Cell Biology, 1997
- Immunological Aspects of Experimental Allergic Encephalomyelitis and Multiple SclerosisCritical Reviews in Clinical Laboratory Sciences, 1995
- Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesionsJournal of Neuroimmunology, 1994
- Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic LesionsScience, 1983
- Chronic relapsing experimental allergic encephalomyelitis: Identification and dynamics of T and B cells within the central nervous systemCellular Immunology, 1982
- Rapid Production of Acute Disseminated Encephalomyelitis in Rhesus Monkeys by Injection of Brain Tissue With AdjuvantsScience, 1946